New norms for TB drugs to ban major brands
The government will soon revise the regulatory code for the fixed dose anti-TB drug combination (FDC) of rifampicin, isoniazid, pyrazinamide and ethambutol. The move would require withdrawal of a
The government will soon revise the regulatory code for the fixed dose anti-TB drug combination (FDC) of rifampicin, isoniazid, pyrazinamide and ethambutol. The move would require withdrawal of a